Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Researcher

Biotechnology · Pakistan · 2023-10-12

Processing Time
10 days
Decision Date
2023-10-12
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on developing successful hormone therapy strategies for uterine cancers, specifically leiomyosarcomas. Her work focuses on identifying particular biomarkers to distinguish rare cancers and diagnosing prognostic factors early in patients' lives using proteomics and genomics.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses uterine cancer, which causes over 13,000 deaths annually in the U.S., demonstrating significant national importance for public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a documented history of 8 publications and 80 citations, showing her peers rely on her expertise.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's specialized knowledge in molecular underpinnings of endocrine disruption makes her a major asset to U.S. health efforts.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in animal biotechnology and a record of 8 peer-reviewed journal articles cited 80 times. Evidence of her expertise included conducting peer reviews for reputable journals and receiving funding from the National Research Foundation of Korea (NRF).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions

Similar Cases

Research Scientist

Healthcare · Iran

WeGreened EB-2 (NIW) rfe approved
546 days 2025-10-16
The petitioner proposes to conduct research in gynecologic oncology, specifically focusing on the prevention, diagnosis, and treatment of cervical, ovarian, and vulvar cancers. Her work aims to identify risk factors and optimize clinical outcomes to reduce cancer mortality and improve evidence-based healthcare policy in the United States.
View Case

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.
View Case

Associate Professor

Healthcare · Taiwan

WeGreened EB-2 (NIW) approved
103 days 2022-04-04
The petitioner proposes to continue developing comprehensive molecular profiling approaches to discover diagnostic biomarkers and therapeutic targets for the precision treatment of cancer. His work specifically focuses on improving effective treatments for gynecological cancers, such as ovarian cancer, through advanced molecular diagnostics.
View Case

Postdoctoral Researcher

Research and Development · Brazil

WeGreened EB-2 (NIW) approved
Texas 265 days 2025-07-23
The petitioner proposes to continue her research in endocrine oncology, specifically focusing on the validation and clinical application of circulating tumor DNA (ctDNA) to detect molecular residual disease. Her work involves coordinating multi-institutional clinical trials and analyzing tumor genetic profiles to optimize treatment strategies for both malignant and benign adrenal lesions. The goal is to improve recurrence-free survival and therapeutic responses for cancer patients undergoing chemotherapy and immunotherapy.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-10-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 10 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist